ArticleEuropean journal of internal medicine2022
Trends of thrombo-inflammation biomarkers after Tocilizumab predict treatment failure better than scores in patients with severe SARS-CoV2 related respiratory failure.
Luca Masotti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.